One explanation for the deterioration of the humoral immune response in elderly individuals is that B lymphopoiesis declines with increasing age. Recent studies report a dramatic decline in pre-B cell numbers in old mice. Surprisingly, the number of mature B cells does not decline with age. To determine if new B cells are made in aged animals despite the drop in pre-B cells, we used 5¢-bromo-2-deoxyuridine labeling to determine the production rate of B cells in the bone marrow and spleen of young and old mice. Because of the great variability in the number of early B lineage cells in old mice, we acquired data on >60 young and 50 old mice throughout these experiments. The transitional and mature B cell compartments in the spleen have slower labeling kinetics in old mice as compared to young. By the end of 4 weeks of labeling, an average of only 15% of the mature B cell compartment consists of newly made cells compared to 30% in young mice. However, in contrast to an earlier report, our results indicate that there is no statistical difference in the rate of production of new immature B cells in the marrow of young and old animals. In total, our results con®rm previous work showing that mature B cells in old mice have a slower turnover, but more importantly suggest that the defect in mature B cell turnover is not due to a decline in B lymphopoiesis, but rather an inability of the newly made cells to replenish the peripheral compartments.
Introduction
Aging impacts the homeostatic function of many complex systems in the body, including the immune system. Elderly individuals experience a higher incidence of disease than younger individuals, including autoimmune disease. In addition, immunizing yields a diminished protective immune response in old as compared to young individuals (1±3). De®ciencies in both the humoral and cell-mediated immune response have been documented. Speci®cally, T h cell function declines with age (4±6), and B cell alterations include production of a greater proportion of low-af®nity antibodies (7, 8) , different V H gene usage (9, 10) and an increased incidence of autoreactive antibodies (11, 12) .
B cells develop in the bone marrow where they progress through a series of stages de®ned by Ig gene rearrangement status and phenotypic marker expression (13, 14) . The pro-B cell compartment contains cells undergoing m heavy chain gene rearrangement. Cytoplasmic m expression and assembly of the pre-B cell receptor mark the progression of pro-B cells into the pre-B cell compartment. After a proliferative burst, these cells become small resting pre-B cells and undergo light chain gene rearrangement. Development into subsequent stages proceeds without proliferation. Immature B cells express surface IgM and are exported to the periphery. The immature B cells in the periphery are referred to as new migrants or transitional B cells and are de®ned by high levels of heat-stable antigen (HSA) and low levels of B220. These cells mature in the periphery into functional B cells (15±17).
Unlike the thymus, which atrophies with age (18) , the bone marrow remains intact and shows no signs of physical atrophy over the lifetime of a rodent. However, it has been well documented that the numbers of B cell precursors in the bone marrow change with age. While the numbers of pro-B cells remain the same in young and old animals, there is a profound decrease in the number of pre-B cells in aged animals (19±23). Paradoxically, this decrease is not accompanied by a similar decline in the immature B cell compartment of the bone marrow or the transitional and mature cells of the periphery (21) . Data showing changes with age in the B lineage based on phenotype alone provide only a snapshot picture of the current status of the B cell precursors, yet provide evidence for altered population dynamics during B cell development. Possible interpretations of these previous results include: (i) aged bone marrow can compensate for the reduction in the number of pre-B cells by allowing a greater proportion of pre-B cells to mature into newly formed B cells or (ii) new B cells are not being made in old animals, but rather a long-lived subset of B cells ®lls these later developmental compartments.
To form a more accurate account of the population dynamics in the B lineage that occur with age, we used 5¢-bromo-2-deoxyuridine (BrdU) labeling to assess the kinetics of B cell development in young and old animals. BrdU is a thymidine analog that is incorporated into the DNA of dividing cells. During B cell development, BrdU incorporates into early progenitor cells and remains with the cell through each developmental stage, effectively marking the cells as`newly made'. Kinetic BrdU-labeling experiments have been used in the past to examine B cell longevity (24, 25) and to follow B cell precursors through development (16) in young mice. These studies demonstrated a rapid renewal of the bone marrow B cells in which 95% of B220 lo cells were labeled with BrdU within 3 days. The new migrant B cells were found to have a slightly longer half-life of 4±7 days, while the mature compartment consisted of mostly long-lived cells with an average halflife of 4±6 weeks. Here, we extend this experimental approach to include both young and old mice. We present a BrdUlabeling time-course experiment ranging from 4 h to 4 weeks, which allowed us to assess the early kinetics of the rapidly renewing B cell populations in the bone marrow and determine the proportion of B cells that join the mature B cell pool in the spleen. Kline et al. used a similar approach to measure the lifespan of B cells in mice of different ages (26) . Unlike the previous study, we looked at the early kinetics (12 h to 11 days) of the bone marrow B cell populations, allowing us to calculate production rates. Additionally, in contrast to the Kline study, we examined a large number of mice (up to 12) at each time point, providing us with a statistical basis for our conclusions and allowing us to comment on the implications of the extreme mouse-to-mouse variability in conducting aging studies. In light of these differences, our data suggest a different conclusion than the previous study. While Kline et al. suggest that new B cell generation in the bone marrow declines with age, we provide evidence that new B cells are generated in old animals at the same rate as in young mice, but are altered in their ability to replenish the peripheral transitional and mature B cell pools. The distinction between these two conclusions is critical for determining the direction of future research.
Methods

Animals
Female BALB/c mice of 2, 12 and 22 months of age were purchased from the National Institute of Aging (Bethesda, MD), whose colony is maintained by Harlan (Indianapolis, IN). Upon receipt, the animals were housed at the Animal Research Facility at Loyola University Medical Center under speci®c pathogen-free conditions.
BrdU administration
For early time points, mice received i.p. injections of 0.8mg of BrdU (Sigma, St Louis, MO) resuspended in 0.2 ml of PBS. Mice loaded with BrdU for a duration of up to 7 days were injected every 12 h. Mice loaded with BrdU for 11 days were injected every 24 h. Mice loaded with BrdU for 2±4 weeks were given drinking water containing 0.25 mg/ml of BrdU. The water was shielded from light and changed every 2±3 days for the duration of the experiment. This concentration of BrdU was established by conducting a pilot study using BrdU at 0.8 and 0.25 mg/ml. When we fed BrdU at 0.8 mg/ml over the course of 4 weeks, we observed a decline in the number of total bone marrow cells, speci®cally B cell precursors. However, when we fed BrdU at 0.25 mg/ml, no decline in precursor B cell number was observed during a course of 4 weeks of labeling and the intensity of BrdU labeling detection was not compromised (data not shown).
Isolation of bone marrow and spleen cells
Spleens were removed and single-cell suspensions were made by rubbing spleens between the frosted ends of two glass slides. Old mice with gross splenic tumors were not used in these experiments. Spleen cells were kept in RPMI 1640 supplemented with 5% FBS (lot 10M44; Summit Biotechnology, Fort Collins, CO), 1% L-glutamine, 1% penicillin/ streptomycin and 5 Q 10 ±5 M b 2 -mercaptoethanol. Cells were pelleted and resuspended in 10 ml of the above media for counting. Bone marrow was isolated by¯ushing tibias and femurs with the above media using a 5-ml syringe and a 26-gauge needle. Aggregated cells were dissociated by pipetting up and down with a 5-ml pipette. Cells were then centrifuged and the cell pellets were resuspended in 5 ml of media for counting. The cells were counted by Trypan blue exclusion.
Staining cells for¯ow cytometry analysis
Two different protocols were used for staining cells for BrdU incorporation. In either case, bone marrow cells were stained with anti-B220±PerCP (RA3-6B2; PharMingen, San Diego, CA), anti-CD43±biotin (S7; PharMingen), anti-IgM±phycoery-thrin (PE) (Jackson ImmunoResearch, West Grove, PA) and anti-BrdU±FITC (B44; Becton Dickinson, San Jose, CA) to distinguish between BrdU-labeled pro-, pre-and immature-B cells. Spleen cells were stained with anti-B220±PE (RA3-6B2; PharMingen), anti-HSA±biotin (M1/69; PharMingen) and anti-BrdU±FITC to distinguish between BrdU-labeled transitional and mature B cells. All antibodies were tittered to determine appropriate dilution. Cells (1 Q 10 6 ) were ®rst stained with anti-IgM±PE (bone marrow) and anti-B220±PE (spleen). After a 20-min incubation on ice, cells were washed in 500 ml of staining buffer (HBSS with calcium/magnesium, 5% heat-inactivated FBS and 0.1% sodium azide). Next, bone marrow cells were stained with anti-CD43±biotin and spleen cells with anti-HSA±biotin for 20 min on ice. At this point one of two protocols was used to permeabilize cells and detect incorporated BrdU. Either the PharMingen BrdU Flow Kit was used according the manufacturer's instructions or the following protocol was used [kindly supplied by Dr Michael Cancro, based on previously published protocols (16, 27) ]. After the above antibody stain, cells were washed with 500 ml of cold PBS. The cells were resuspended in another 500 ml of cold PBS and permeabilized with 1.2 ml of 95% ice-cold ethanol added at 1 drop/s while slowly vortexing. After a 20-min incubation on ice, cells were washed with 500 ml of cold PBS. Then 100 Kunitz U DNase (Sigma) was added to each sample and incubated at 25°C for 20 min to denature the DNA and expose incorporated BrdU. Next, cells were ®xed in 1 ml of 1% paraformaldehyde plus 0.05% Tween and incubated at room temperature for 20 min followed by a 20-min incubation on ice. Independent of the protocol used, all cells were stained with anti-BrdU±FITC and incubated on ice for 20 min. For the ®nal stain, the bone marrow cells were stained with anti-B220± PerCP plus streptavidin±allophycocyanin to develop the antiCD43±biotin. Spleen cells received streptavidin±allophyco-cyanin to develop the HSA±biotin. For each experiment, a set of samples was stained for surface phenotype markers without the permeabilization and DNase steps to control for effects of these treatments on cell surface pro®les. These samples were ®xed in 1% paraformaldehyde. Flow cytometry analysis was done using a FACSCalibur and data was analyzed using CellQuest software (Becton Dickinson).
Calculation of production rate
The production rate was calculated using least-squares regression analysis of the linear portion of the plot`number of labeled cells' versus`time'. The regression line was ®tted through at least three points and was not forced through the origin. The regression coef®cient represents the number of cells produced per day.
Statistical analysis
To compare numbers of B lineage cells, and total numbers of bone marrow and spleen cells between age groups, Student's t-test was used. Production rates were compared using analysis of covariance (comparison of slopes). P < 0.05 was considered signi®cant. InStat by GraphPad and SPSS software was used for analysis.
Results
Numbers of B-lineage subsets in the bone marrow of young and old BALB/c mice
One hallmark change within the B cell lineage of an old mouse is a decline in the number of pre-B cells. Published studies on absolute numbers of B cells in the bone marrow of old mice report no change in the number of pro-B cells, but a 2-to 4-fold decrease in the number of pre-B cells in old mice as compared to young (19±23). The number of immature B cells, however, has been shown to decrease <2-fold in old mice (21) . The experiments performed here on 2-and 22-month-old BALB/c mice are generally in agreement with previous reports. Our study, which took place over a 30-month period, included >60 young and 50 old mice purchased from the National Institute of Aging's aging colony at Harlan. Similar to previous studies, we found an overall increase in the number of bone marrow cells in old animals as compared to young (Table 1) and the number of pre-B cells was signi®cantly decreased bỹ 30% in old mice ( Table 2) . Despite a signi®cant decrease in the percent of pro-and immature B cells in old mice, there was no signi®cant decrease in the actual numbers of pro-and immature B cells as compared to young mice (Table 2 ) due to the increase in the overall cellularity. The number of B220 hi mature recirculating bone marrow B cells was increased in old animals, accounting for~10% of the increase in total bone marrow cellularity ( Table 2 ).
Labeling of precursor B cells in the bone marrow of young and old mice
In order to determine if new B cells are made from the reduced pool of precursors in old mice, we compared the kinetics of B cell development in 2-and 22-month-old animals by labeling young and old mice with BrdU over a course of 4 weeks. For the early time points (4 h to 11 days), BrdU was administered by i.p. injection, but for the later time points (2 and 4 weeks) BrdU was fed in the drinking water to avoid toxicity. Bone marrow cellularity and total numbers of B220 + cells were maintained throughout BrdU treatment, suggesting negligible toxic effects. We analyzed >100 mice combined in these experiments and at the pivotal early time points (12 h to day 3) we analyzed six to eight mice of each age group.
After BrdU treatment, bone marrow was harvested and cell surface phenotype and BrdU incorporation was determined by¯ow cytometry analysis. A sample pro®le, including the gates we used to distinguish the different B cell subsets, is shown in Fig. 1 . In both young and old mice, the pro-B cell compartment (B220 lo /CD43 + /IgM ± , Hardy fractions A-C¢), which contains the rapidly proliferating compartment of developing B cells, fully labeled within 1±2 days of BrdU administration ( Fig. 2A) . The pre-B cell compartment (B220 lo / CD43 ± /IgM ± , Hardy fraction D) in both age groups was fully labeled by day 3 (Fig. 2B ). The immature B cells (B220 lo / CD43 ± /IgM + , Hardy fraction E) of young mice reached maximum BrdU labeling at~95% by day 7 (Fig. 2C ), while in old c Cells in each organ were counted (for bone marrow, cells from two tibias and two femurs were combined) and the number of cells at each stage was calculated by multiplying the percentage of cells in that compartment by total numbers of live-gated bone marrow or spleen cells. Note: numbers were not corrected for total body marrow using Osmond's estimated conversion factor (29) . For bone marrow subsets, data represent the mean of 56 young mice and 51 old mice; spleen subsets represent 60 young mice and 55 old mice T SE. *P < 0.05, **P < 0.0001.
An earlier publication suggested a more severe defect in immature B cell production in old animals than what we report here, speci®cally in an IgM hi subset (26) . For comparison, we divided the immature B cells into IgM lo and IgM hi populations.
In our experiments, we saw similar numbers of IgM lo B cells in young and old mice (Table 2) , and little difference in the labeling kineticsÐ95% of the IgM lo cells labeled by day 11 in both age groups (Fig. 3A ). There were, however,~30% fewer IgM hi immature B cells in old mice when compared to young IgM hi immature cells ( Table 2 ). The IgM hi cells from old mice reached maximum labeling at only 70% after 7 days of BrdU injection compared to maximum labeling at 95% in young mice (Fig. 3B) .
The early time points in the labeling experiments presented here allowed us to predict the production rate (number of cells produced per day in two tibias and two femurs) from the total number of labeled cells in each bone marrow compartment over time (Table 3) . Similar numbers of new pro-B cells were made per day in young and old animals (1.46 Q 10 6 and 1.28 Q 10 6 respectively). Pre-B cell production was signi®cantly decreased from 3.57 Q 10 6 cells/day in young mice to 2.56 Q 10 6 cells/day in old mice. In old animals, 0.82 Q 10 6 immature B cells were produced per day, which was a slight increase over the 0.73 Q 10 6 produced per day in young mice. This increase in production paralleled the IgM lo subpopulationÐ 0.25 Q 10 6 cells were produced per day in young mice versus the 0.37 Q 10 6 produced per day in old mice. Approximately 0.4 Q 10 6 IgM hi cells were produced per day in both young Bone marrow was harvested at 12 h, 1, 2, 3, 7 and 11 days, and 2 and 4 weeks post-labeling, and cells were stained with antibodies to phenotypic markers to distinguish (A) pro-, (B) pre-and (C) immature B cell subsets, and stained with anti-BrdU±FITC to detect BrdU incorporation as described in Methods. The percent labeled cells was determined by¯ow cytometry using CellQuest software. n = 6±12 mice at 12 h, 1, 2, 3 and 7 days, and 2 weeks; n = 3 at 11 days and 4 weeks. In (C), the BrdU labeling pro®le of 12-month-old mice (to day 7) is included (n = 3±12 mice at each time point). Data represent means T SE. Fig. 3 . Kinetics of BrdU labeling of the IgM hi and IgM lo immature B cell subsets of young and old mice. The pro®les generated as described in Fig. 2 were reanalyzed, and the immature B cell population was divided into (A) IgM hi and (B) IgM lo cells. Because the IgM + cells did not fall into two distinct populations, IgM lo cells were arbitrarily de®ned as the lower one-fourth of the total IgM + gated population (see Fig. 1 ). n = 6±12 mice at 12 h, 1, 2, 3 and 7 days, and 2 weeks; n = 3 at day 11 and 4 weeks. Data represent means T SE. Numbers and kinetics of B-lineage subsets in the spleens of young and old animals
To determine if the newly made immature B cells accumulate in the spleen of old mice, we examined the magnitude and kinetics of the transitional and mature B cell compartments. On average, the old mice had a signi®cant increase in the number of spleen cells as compared to young mice (Table 1) . No signi®cant difference was seen in the frequency of B220 + cells in the spleens of 2-and 22-month-old animals (data not shown). Data published previously by our laboratory showed that the number of transitional and mature peripheral B cells does not change signi®cantly with age (21) . Here, as before, we de®ned transitional B cells as HSA hi and B220 lo , while the mature subset was de®ned as HSA lo and B220 hi (see Fig. 4 for sample pro®les and gating). The population of cells expressing both high levels of HSA and B220 was excluded from these gates because we have observed that these cells have an activated phenotype (high levels of surface IgM and a high forward scatter, indicative of large cell size; unpublished data). When gated in this way there was no signi®cant difference in the frequency or number of transitional and mature B cells between young and old animals ( Table 2) .
At each time point over the course of 4 weeks of BrdU labeling, spleen cells were stained to discriminate between BrdU-labeled transitional B cells and mature B cells. The frequency of labeled transitional B cells (HSA hi /B220 lo ) continued to increase over time in the young animals, plateauing Table 2 . b Production rates were determined by plotting the number of labeled cells produced per day over time. Number of labeled cells was calculated by multiplying the percentage labeled cells in that compartment (as determined by¯ow cytometry analysis) by total numbers of cells in that compartment (calculated as in Table 2 ). Production rates were predicted by the slope of the linear portion of the curves in the plots using linear regression analysis. The speci®c time points used to draw the regression lines are as follows: 4-and 12-h, and 1-day time points were used to calculate the rate of proand pre-B cell production; 4-and 12-h, and 1-and 2-day time points were used to calculate the rate of immature B cell production; 12-h through 11-day time points were used to calculate the rate of transitional cell production; and 12-h through 4-week time points were use to calculate the rate of mature B cell production. *P < 0.05, **P < 0.0005 by analysis of covariance. at 70% by 2 weeks (Fig. 5A) . In contrast, transitional B cells in the old animals plateaued at~40% in this same time period (Fig. 5A) . It was considered that marginal zone B cells fall within the transitional B cell gate and that this population increases with age. The majority of CD23 ± /CD21 hi marginal zone B cells fell within the mature HSA lo /B220 hi gate, indicating that marginal zone B cells are not contributing to the population dynamics of the transitional B cell pool in either age group (data not shown). New, labeled mature B cells (HSA lo /B220 hi ) continued to accumulate in young and old mice, and maximum labeling was not reached in this 4-week period. Thirty percent of the mature B cell compartment in young mice renewed with BrdU-labeled cells after 4 weeks, but in old mice only 15% of the mature compartment renewed in this time (Fig. 5B) .
The production rate was also calculated for the splenic B cell subsets in young and old mice. This rate represents the number of new cells (assumed to be coming from the bone marrow) that appear in the spleen over time. As shown in Table 3 , 43% fewer transitional B cells accumulated per day in old mice as compared to young and the mature B cell compartment showed an even greater kinetic de®ciency. Fiftyeight percent fewer newly made cells appear in the mature B cell compartment of old animals compared to young (Table 3) .
Comparison of middle-aged mice to young and old
In order to address when during the lifetime of a mouse the changes in B cell development begin, we studied the labeling kinetics of a set of middle-aged (12-month-old) BALB/c mice. The middle-aged mice show an intermediate decline in the relative size of the pre-and immature compartments and an increase in the B220 hi mature recirculating bone marrow compartment (data not shown). The labeling kinetics of the immature and transitional B cell compartments over seven days in 12-month-old mice also demonstrates an intermediate phenotype to young and old mice (Figs 2C and 5A) . Together, this data suggest that the alteration in B cell development begins prior to 12 months of age and new B cell production progressively slows with time.
Correlation between the number of pre-B cells and severity of the kinetic defect in old mice
One puzzling inconsistency in the data from this study and that from the study by Kline et al. is the discrepancy between the severity of the production of new B cells in old mice (26) . Kline et al. suggested that old mice have a severe defect in the production of new immature B cells based on a group of mice that all had a severe defect in pre-B cell numbers. In contrast, our data suggest that, on average, B cell production in the bone marrow is only modestly affected by age. While some old mice in our study had a severe drop in pre-B cell numbers, others fell within the range of young mice (Fig. 6A) . We investigated the possibility that new B cell production correlates with the severity of the pre-B cell de®ciency. Sherwood et al. have shown a similar correlation between pre-B cell numbers and defects in old mice (23) .
In order to determine if the number of pre-B cells correlates with the number of new B cells that are made, we grouped all our old mice into those with`low' pre-B cell numbers (range = 1.1±2.85 Q 10 6 ) and those having`high' pre-B cell numbers (range = 3.38±8.25 Q 10 6 ), and plotted the number of labeled immature and transitional B cells over time for each group. Figure 6 (B and C) illustrates the compared production of immature and subsequent accumulation of transitional B cells in the spleen between these two groups. Fewer BrdU-labeled immature B cells accumulated over time in the`low' pre-B cell number group as did in the`high' pre-B cell number group, but the number of labeled immature B cells accumulating over time in the`high' group was similar to young mice (Fig. 6B) . The difference between the`low' and`high' pre-B cell number groups was more dramatic in the transitional B cell compartment of the spleen. Approximately half as many BrdU-labeled cells accumulated in the`low' pre-B cell group at the later time points compared to the`high' pre-B cell group, yet the appearance of new transitional B cells in the periphery was still de®cient in the`high' pre-B cell group as compared to young (Fig. 6C) . Young mice similarly split based on low-end (range = 1.67±4.85 Q 10 6 ) and high-end (range = 5.00±10.30 Q 10 6 ) pre-B cell numbers did not show this correlation (Fig. 6D) . Therefore, the previous study (26) , which looked at Fig. 5 . Kinetics of BrdU labeling of the transitional and mature B cell compartments of young and old mice. Spleens were harvested from the mice described in Fig. 1 . Spleen cells were stained with antibodies to phenotypic markers to distinguish (A) transitional and (B) mature B cell subsets, and stained with anti-BrdU±FITC to detect BrdU incorporation as described in Methods. The percent of labeled cells was determined by¯ow cytometry using CellQuest software. n = 6±12 mice at 12 h, 1, 2, 3 and 7 days, and 2 weeks; n = 3 at 11 days and 4 weeks. In (B), the BrdU labeling pro®le of 12-monthold mice (to day 7) is included (n = 3±12 mice at each time point). Data represent means T SE.
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Discussion
New B cell production in the bone marrow of aged mice
In order to form a more accurate representation of the population dynamics in the B lineage with age, we assessed the kinetics of B cell development in young and old animals by measuring the accumulation of BrdU-labeled cells at each developmental stage. While the number of B cells in the bone marrow and spleen does not change with age, it cannot be assumed that new B cells are being made or that new mature B cells replenish residing cells in the spleen. If we are to understand how humoral immune system function declines with age, we must ®rst document the changes in B cell development.
One explanation for the decline in B cell function with age is that new B cell production ceases in old individuals, as has been recently proposed (26) . Our data challenge this conclusion based on the ®nding that there are only moderate kinetic differences in the immature B cell compartment of young and old mice. Speci®cally, similar numbers of new BrdU-labeled immature B cells are made per day in old mice as compared to young mice, despite a population of immature B cells in old mice that never accumulates labeled cells. It may appear counter-intuitive that the production rate is the same, when, in the old mice, maximum labeling is never reached. However, the kinetically active (linear portion) and the stagnant (unlabeled 25%) populations are distinct from one another and are therefore considered independently (28) . Further analysis revealed that the kinetically stagnant population resides in the IgM hi subgroup of immature B cells. Although the identity of this unlabeled fraction of cells is unclear, we propose two possibilities that could explain their presence. One proposition is that these long-lived cells may be recirculating mature B cells. Because they are gated on B220 lo , an established indicator of immature B cells, this possibility would be correct only if a proportion of mature B cells in old mice can change their cell surface phenotype and simultaneously down-regulate B220 and up-regulate IgMÐa phenomena not reported in young mice. Another proposition that we offer is that this is a population of immature B cells with increased longevity. While we cannot dismiss the possibility that a fraction of mature recirculating B cells change their phenotype and are captured in our immature B cell gate, there is no supporting evidence in the literature for such a phenotypic change with age. We argue that an increased longevity within the immature compartment is a more likely explanation based on unpublished data from our laboratory. We have seen that early B lineage cells from old mice survive longer in culture than those from young mice.
Our data provide evidence that the production of new cells in the bone marrow of aged mice is sustained despite the decreased size of the pre-B cell pool. In normal young mice, millions of new pre-B cells are made every day (29) , but over half of these cells are lost before exiting the bone marrow due to unsuccessful gene rearrangement (30, 31) or negative selection upon encounter with self-antigen (32, 33) . Because fewer pre-B cells are made per day in old animals without affecting new immature B cell production, it is likely that the mechanisms that tightly regulate the production of new B cells are relaxed in old mice. This has important implications for proposing models of immune dysfunction with age. For example, in old mice (i) a greater proportion of pre-B cells could be recruited into the immature B cell pool or (ii) fewer immature B cells could succumb to selection against selfantigen. In either case, important quality control checkpoints may be compromised in exchange for quantity of output, potentially leading to the production of autoreactive and functionally defective B cells.
Renewal of the transitional and mature B cell compartments in aged mice
The number of spleen cells and the proportion of splenic B lineage cells in our study did not decline with age. This is in striking contrast to the number of spleen cells reported by Kline et al. On average, the old mice in our study had increased numbers of total spleen cells as compared to young mice (young = 129 Q 10 6 versus old = 157 Q 10 6 cells). In studies using hundreds of aged mice over several years, we never observed spleens as acellular as those in the report by Kline et al. (old = 38 Q 10 6 cells) (26) . Additionally, in contrast to the previous report, but corroborating previous data from this laboratory (21), we detected no signi®cant decline in the number of transitional B cells when we used HSA and B220 as phenotypic markers to distinguish transitional and mature B cells [as established by Allman et al. (15, 16) ]. The rapid accumulation of BrdU-labeled cells in the HSA hi /B220 l°p opulation in young mice supports this designation as transitional B cells.
Despite the maintenance of peripheral B cell numbers and despite the relatively conserved production of immature B cells in the bone marrow of old mice, the ability of new cells to replenish the splenic B cell pools is compromised. The transitional B cell compartment in young mice reaches maximum labeling within 2 weeks, which corroborates previous kinetic analysis of this compartment (16, 25) . However, the kinetic pro®le of the transitional B cells in old mice is markedly different from their young counterpart. The production rates indicate that almost half as many new transitional B cells are produced per day in old mice as compared to young. The transitional B cell compartment in old mice reaches maximum labeling within 2 weeks, as is the case with young mice, but plateaus at only 40% of the total gated population. This kinetic pattern suggests, again, the presence of two populations of cells in old miceÐa kinetically active population that labels slower than their young counterpart (represented by the more negative slope) and a large (60% of the population) stagnant pool that fails to renew with new cells after 4 weeks of labeling. A transitional B cell compartment that contains long-lived cells has important functional implications. It has been shown that transitional B cells remain functionally immature and undergo apoptosis upon IgM cross-linking (16, 17) . B cells that reside in this compartment for an extended amount of time may be less sensitive to negative selection mechanisms and thus become recruited into the mature B cell pool as functionally defective or even autoreactive cells.
Based on the ®nding that fewer new, BrdU-labeled transitional B cells are observed in the spleens of old mice, one would predict that fewer labeled cells would also accumulate at the mature B cell stage in these mice. Con®rming this prediction, BrdU-labeled cells account for only 15% of the total mature B cell compartment in aged mice after a 4-week period as compared to 30% in the mature B cell compartment of young mice. The accumulation of new mature B cells in young and old mice continues to increase linearly during the 4-week labeling period, but at different rates. Fifty-eight percent fewer new mature B cells are produced per day in old mice as compared to young mice. Because the size of the mature B cell compartment is the same in both age groups, we can conclude that cells in this compartment of old mice are also longer lived than mature B cells in young mice. Increased survival of mature B cells may have profound effects on effector function. Although the physiological mechanism by which an increased cell life span would affect B cell function is not known, we speculate that the documented decline in B cell function with age is related to the failure of the compartment to replenish with newly made cells every 4±6 weeks.
Variability in pre-B cell numbers and correlation to kinetic de®ciencies
One consistent sign of aging repeatedly reported in the literature is the sharp decline in pre-B cell numbers (19±23). However, within our study group of 51 old mice, pre-B cell numbers range from 1.11 to 8.25 Q 10 6 /two tibias and two femurs, with some mice falling within the average range of pre-B cell numbers reported in young mice. Sherwood et al. addressed the correlation between pre-B cell numbers and B cell defects, and demonstrated that old mice with low pre-B cell numbers have less expression of l5 protein, while old mice with`young-like' pre-B cell numbers express similar levels of l5 as young mice (23) . In our study, old mice with high' pre-B cell numbers accumulate a greater number of labeled immature cells over time as compared to old mice with`low' pre-B cell numbers, suggesting that new B cell B cell development in aged animals 1321 at Pennsylvania State University on February 23, 2013 http://intimm.oxfordjournals.org/ Downloaded from production may be dependent on the severity of the pre-B cell defect. This correlation is even more dramatic in the splenic transitional B cell compartment of old mice. Half as many new transitional B cells accumulate over time in old mice with`low' numbers of pre-B cells compared to old mice with`high' numbers of pre-B cells. Notably, the old mice with`high' pre-B cell numbers (average 4.98 Q 10 6 cells) are still kinetically impaired compared to young mice (average 5.00 Q 10 6 pre-B cells). Additionally, young mice with low-end pre-B cell numbers are not kinetically different from young mice with high-end pre-B cell numbers. Together, this suggests that pre-B cell number alone does not govern the ultimate ability of these cells to progress through development, but rather intrinsic and/or environmental de®ciencies in old mice beyond the pre-B cell stage play a role in this development defect. Moreover, we still maintain that the major defect in B cell development of old mice is the inability of newly made cells to join the peripheral B cell compartments.
Potential mechanisms for altered mature B cell turnover
The main contribution of our studies is the evidence that the decline in mature B cell turnover is not accompanied by a severe decline in new B cell production. This evidence refutes previous work. Kline et al. suggest that there is a severe defect in new B cell production in the bone marrow of old mice. The distinction between these two conclusions is critical for determining the direction of future research. Our current hypotheses are directed toward determining mechanisms for the altered survival of immature B cells and/or the altered migration of newly made B cells to the spleen of aged mice. The alternate conclusion would warrant focusing efforts on determining the mechanism of altered B lymphopoiesis with age.
We propose several explanations for why newly made cells do not replenish the mature B cell compartment. The speci®c cues for the recruitment of transitional B cells into the longlived mature B cell pool have recently been shown to include the expression of a functional BCR (34) and the environmental survival signal BAFF (35) . Because new immature B cells are being made from a reduced population of precursors in aged animals, the regulation at the pre-to immature B cell transition may be less stringent, allowing cells with defective receptors to enter the periphery, just to fail at a later check point. Alternatively, signals provided by the surrounding environment/accessory cells may be altered with age. Another likely mechanism for the failed replenishment of peripheral B cells is a defective homing mechanism. Newly made B cells may be unable to exit the bone marrow and die in situ after a few days. Alternatively, assuming new B cells successfully leave the bone marrow, they may be unable to respond to homing signals required for the migration out of the blood and into the spleen. An interesting question that remains unexplored is whether B cell longevity increases in aged mice in response to a diminished supply of new emigrants from the bone marrow or whether longevity is pre-programmed and thus new immature B cells are unable to successfully compete for space with the residing cells.
